Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: ecf w/ plans for operative intervention, admitted for nutrition and w/u of fungal septicemia. major surgical or invasive procedure: 1. takedown of enterocutaneous fistula. 2. resection of abdominal wall. 3. small bowel resection with enteroenterostomy. 4. massive lysis of adhesions greater than 2.5 hours. 5. ventral hernia repair with veritas mesh (3 large meshes with 4 suture lines to piece it together). history of present illness: pt seen in clinic for f/u of ecf. found to have fungal line infection 7-10d prior to admission. admitted to hospital for w/u of fungemia prior to operating on the fistula and large ventral hernia. past medical history: pmh: ec fistula h/o decubitus ulcers pt has fetal anomaly, incomplete circle of dm hypothyroidism-pt denies morbid obesity anemia h/o frequent utis respiratory failure with last operation oa arf with last two operations htn psh: -exploratory laparotomy, lysis of adhesions (3 hours), enterectomy and/or enterostomy, closure enterotomy and repair of hernia with vicryl mesh -s/p fistula repair at 5y ago -multiple ex-lap/loa -multiple incisional herniorrhaphy -ccy -appy social history: occassional tobacco use, denies etoh use lives with husband and kids family history: noncontributory physical exam: physical exam on admission: vitals- t 97, hr 91, bp 118/80, rr 18, o2sat 91% 2l nc gen- nad, alert head and neck- at, nc, soft, supple, no masses heart- rrr, no murmurs lungs- coarse bs bilaterally abd- +bs, soft, nt, nd, fistula has vac ext- warm, well-perfused, no edema pertinent results: 06:45pm urine color-yellow appear-clear sp -1.000* 06:45pm urine blood-mod nitrite-neg protein-neg glucose-neg ketone-neg bilirubin-neg urobilngn-neg ph-5.0 leuk-sm 06:45pm urine rbc-0-2 wbc-0-2 bacteria-occ yeast-none epi-<1 05:00pm glucose-143* urea n-26* creat-1.1 sodium-139 potassium-4.4 chloride-103 total co2-26 anion gap-14 05:00pm estgfr-using this 05:00pm calcium-9.2 phosphate-2.8 magnesium-1.8 05:00pm wbc-8.0 rbc-3.22* hgb-9.3* hct-29.0* mcv-90 mch-28.9 mchc-32.1 rdw-17.0* 05:00pm neuts-65.3 bands-0 lymphs-27.0 monos-5.1 eos-2.2 basos-0.5 05:00pm hypochrom-1+ anisocyt-1+ poikilocy-normal macrocyt-normal microcyt-normal polychrom-occasional 05:00pm plt smr-normal plt count-336# 05:00pm pt-16.2* ptt-31.0 inr(pt)-1.5* brief hospital course: admitted to hospital for w/u fungemia and possible operative intervention for ecf and large ventral hernia. seen by wound/ostomy care. pt relatively stable. tpn. followed nutrition labs. followed vac. found to have +ucx, started on cipro. found to have albumin 2.9. postponed or to rx uti, eval nutrition. started on meropenem per id. meropenem course d/c-ed. continued tpn. followed nutrition labs. managed vac. prepped for or. ecf takedown, small bowel resection, large ventral hernia repair performed. pt to icu on vent and pressors due to history of respiratory decompensation s/p surgery. wound found to have progressed; opened & up and vac placed. started on linezolid & zosyn. off all pressors & weaned off vent. drain fluid sent for cultures, finding proteus and staph; id recommended continuing linezolid and zosyn. on tpn. stable. transferred to floor. continued tpn. passed flatus. multiple bm, diarrheal. sent cdiffx3. started flagyl empirically. linezolid, zosyn, flagyl d/c-ed given worsening renal function (cr bump to 2.2) and question of hypovolemia vs atn. advanced to full diet; tolerated well. trigger event with ams. found to be aox3. sleep apnea likely. cpap instituted. cr to 3.1 o/n. cr improved with fluid bolus 3.5l. pt febrile, poor sats. fever w/u instituted. rll pna found on cxr. levo/flagyl begun for pna/asp pna white count spike to 16.0 white count falling. afebrile. sats & symptoms improved. continuing diarrhea, cdiff sent. +cdiff. oral vanco begun. flagyl and levo continued as po. clinically, diarrhea and pna resolving. cr stable in 1.6-1.9 range. pt doing well. sx resolved. vac in place w/ good granulation & beginning contraction. avss. d/c for further after-hospital care. medications on admission: 1. toprol xl 100 mg po daily 2. lisinopril 20 mg po bid 3. miconazole nitrate 2 % powder topical 4. calcium carbonate 500 mg po tid 5. tizanidine 2 mg po qhs 6. acetaminophen 650 mg po q6h 7. ranitidine hcl 150 mg po daily 8. gabapentin 300 mg po tid 9. tramadol 50 mg po q6h 10. furosemide 20 mg po daily discharge medications: 1. miconazole nitrate 2 % powder sig: one (1) appl topical (2 times a day). 2. heparin (porcine) 5,000 unit/ml solution sig: one (1) inj injection tid (3 times a day). 3. camphor-menthol 0.5-0.5 % lotion sig: one (1) appl topical tid (3 times a day) as needed. 4. albuterol 90 mcg/actuation aerosol sig: 1-2 puffs inhalation q4h (every 4 hours). 5. lidocaine hcl 2 % gel sig: one (1) appl mucous membrane prn (as needed). 6. metoprolol succinate 100 mg tablet sustained release 24 hr sig: one (1) tablet sustained release 24 hr po daily (daily). 7. gabapentin 300 mg capsule sig: one (1) capsule po bid (2 times a day). 8. acetaminophen 325 mg tablet sig: two (2) tablet po q6h (every 6 hours) as needed. 9. omeprazole 20 mg capsule, delayed release(e.c.) sig: one (1) capsule, delayed release(e.c.) po daily (daily). 10. albuterol sulfate 2.5 mg /3 ml (0.083 %) solution for nebulization sig: 1-2 puffs inhalation q6h (every 6 hours) as needed. puffs 11. insulin regular human 100 unit/ml solution sig: one (1) inj injection asdir (as directed). 12. ibuprofen 400 mg tablet sig: one (1) tablet po q8h (every 8 hours). 13. metronidazole 500 mg tablet sig: one (1) tablet po tid (3 times a day) for 5 days. 14. levofloxacin 750 mg tablet sig: one (1) tablet po q24h (every 24 hours) for 5 days. 15. vancomycin 125 mg capsule sig: one (1) capsule po q6h (every 6 hours) for 12 days. 16. ondansetron hcl (pf) 4 mg/2 ml solution sig: one (1) injection q8h (every 8 hours) as needed. 17. hydromorphone (pf) 1 mg/ml syringe sig: one (1) dose injection q6h (every 6 hours) as needed. discharge disposition: extended care facility: nursing and rehab center for discharge diagnosis: enterocutaneous fistula with abdominal wall disruption and ventral hernia with loss of eminent domain. discharge condition: stable discharge instructions: please call your surgeon if you develop chest pain, shortness of breath, fever greater than 101.5, foul smelling or colorful drainage from your incisions, redness or swelling, severe abdominal pain or distention, persistent nausea or vomiting, inability to eat or drink, or any other symptoms which are concerning to you. activity: no heavy lifting of items 20 pounds until the follow up appointment with your doctor. medications: resume your home medications. you should take a stool softener, as needed for constipation. pain medication may make you drowsy. no driving while taking pain medicine. followup instructions: please call dr. at to schedule your follow-up appointment. procedure: venous catheterization, not elsewhere classified parenteral infusion of concentrated nutritional substances other partial resection of small intestine arterial catheterization other lysis of peritoneal adhesions closure of fistula of small intestine, except duodenum other and open repair of other hernia of anterior abdominal wall with graft or prosthesis excision or destruction of lesion or tissue of abdominal wall or umbilicus injection or infusion of oxazolidinone class of antibiotics diagnoses: pneumonia, organism unspecified other postoperative infection urinary tract infection, site not specified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure pneumonitis due to inhalation of food or vomitus other specified septicemias intestinal infection due to clostridium difficile other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation morbid obesity osteoarthrosis, unspecified whether generalized or localized, site unspecified infection and inflammatory reaction due to other vascular device, implant, and graft methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site other and unspecified mycoses fistula of intestine, excluding rectum and anus intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) ventral, unspecified, hernia without mention of obstruction or gangrene personal history of methicillin resistant staphylococcus aureus other specified congenital anomalies of brain dietary surveillance and counseling 

Answer: The patient is high likely exposed to